{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:35:50Z","timestamp":1753889750503,"version":"3.41.2"},"reference-count":32,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"name":"Ministry of Education, Culture, Research, and Technology, the Republic of Indonesia, through PDUPT","award":["NKB-065\/UN2.RST\/HKP.05.00\/2021"],"award-info":[{"award-number":["NKB-065\/UN2.RST\/HKP.05.00\/2021"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>This study aims to determine the prevalence of Type 2 Diabetes Mellitus (T2DM)\nin primary Brain Tumor (BT) subjects and assess the relationship between serum mutant p53 serum\nand HbA1c and insulin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>T2DM is known to increase the risk of various types of cancer, which are thought to\nbe caused by hyperglycemia, hyperinsulinemia, and inflammation. A cohort study that looked at\nmore than 500,000 subjects with DM over 11 years showed an increased risk of different types of\ncancer, including brain tumors. However, several recent studies have shown the opposite. One of\nthe important pathways in the pathogenesis of brain tumors is the p53 pathway, in which mutations\nin the TP53 gene can cause brain cell growth abnormalities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The first stage involved taking subject data for the period January 2017-November 2020\nfrom the medical records of the RSUPN Dr. Cipto Mangunkusumo Hospital Indonesia to assess the\nprevalence of T2DM in BT subjects. The second stage was an observational study with a crosssectional\ndesign that collected primary data on subjects (n=86) to assess the relationship between\nserum mutant p53 serum and HbA1c and insulin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The analysis of serum mutant p53 serum and insulin was made using the ELISA method,\nwhile measurement of HbA1c was made using the boronate affinity method.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results show the prevalence of T2DM in BT subjects at Dr. Cipto Mangunkusumo\nHospital Indonesia was relatively low (9%). Serum mutant p53 levels in T2DM (1.53 ng\/mL \u00b1 0.60)\nwere significantly higher than in BT+T2DM and BT (P &lt; 0.001). The HbA1c value was significantly\nlower in BT (5.15% \u00b1 0.44) compared to BT+T2DM and T2DM (P &lt; 0.001), while T2DM insulin\nlevels (39.54 IU\/mL \u00b1 19.1) were significantly higher than BT+T2DM and BT (P &lt; 0.001). There\nwas no correlation between serum mutant p53 levels and HbA1c and insulin in the three groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The study concludes that the prevalence of BT with T2DM is relatively low (9%) and\nthat serum levels of mutant p53 in T2DM subjects are higher than in subjects with BT, but there is\nno correlation between serum mutant p53 levels and HbA1c and insulin values. Further research\nneeds to be conducted by analyzing p53 mutants from other specimens, such as brain tumor tissue.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399818666220519140903","type":"journal-article","created":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T12:57:40Z","timestamp":1653224260000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Absence of Association Between Serum Mutant p53 with HbA1c and\nInsulin in Brain Tumor Patients with Type 2 Diabetes Mellitus"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-4369","authenticated-orcid":true,"given":"Rani","family":"Sauriasari","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Indonesia, Depok, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hardiyanti","family":"Syarif","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Indonesia, Depok, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Famila","family":"Takhwifa","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Indonesia, Depok, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiara","family":"Aninditha","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, University\nof Indonesia, Jakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"Diabetes Federation International. IDF Diabetes Atlas Ninth edition 2019. International Diabetes Federation 2019. Available from:"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/aje\/kwv290","volume":"183","author":"Dankner R.","year":"2016","unstructured":"Dankner R.; Boffetta P.; Balicer R.D.; Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults. Am J Epidemiol 2016,183(12),1098-1106","journal-title":"Am J Epidemiol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3892\/etm.2012.698","volume":"4","author":"Tong J.J.","year":"2012","unstructured":"Tong J.J.; Tao H.; Hui O.T.; Jian C.; Diabetes mellitus and risk of brain tumors: A meta-analysis. Exp Ther Med 2012,4(5),877-882","journal-title":"Exp Ther Med"},{"key":"ref=4","unstructured":"World Health Organization. Indonesia Source GLOBOCAN 2018. International Agency for Research on Cancer 2019; 256: 1-2. Available from:"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1038\/bjc.2014.150","volume":"110","author":"de Beer J.C.","year":"2014","unstructured":"de Beer J.C.; Liebenberg L.; Does cancer risk increase with HbA1c, independent of diabetes? Br J Cancer 2014,110(9),2361-2368","journal-title":"Br J Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.annepidem.2018.11.010","volume":"30","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Sun Y.; Tang J.; Does diabetes decrease the risk of glioma? A systematic review and meta-analysis of observational studies. Ann Epidemiol 2019,30,22-29.e3","journal-title":"Ann Epidemiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/CAD.0b013e32834258a1","volume":"22","author":"Chaves J.","year":"2011","unstructured":"Chaves J.; Saif M.W.; IGF system in cancer: From bench to clinic. Anticancer Drugs 2011,22(3),206-212","journal-title":"Anticancer Drugs"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-2007-981215","volume":"30","author":"Langen K-J.","year":"2007","unstructured":"Langen K-J.; Stoffels G.; Brain Tumors (A Handbook For The Newly Diagnosed). Nuklearmediziner 2007,30(3),204-211","journal-title":"Nuklearmediziner"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.12865\/CHSJ.40.01.05","volume":"40","author":"Alexandru O.","year":"2014","unstructured":"Alexandru O.; Ene L.; Purcaru O.S.; Plasma levels of glucose and insulin in patients with brain tumors. Curr Health Sci J 2014,40(1),27-36","journal-title":"Curr Health Sci J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/bjc.2016.157","volume":"115","author":"Bernardo B.M.","year":"2016","unstructured":"Bernardo B.M.; Orellana R.C.; Weisband Y.L.; Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality. Br J Cancer 2016,115(1),108-114","journal-title":"Br J Cancer"},{"key":"ref=11","first-page":"2-6","year":"2019","unstructured":"ADA Standards of Medical Care in Diabetes 2019,2-6","journal-title":"ADA Standards of Medical Care in Diabetes"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14423\/SMJ.0000000000000214","volume":"108","author":"Gray N.","year":"2015","unstructured":"Gray N.; Picone G.; Sloan F.; Yashkin A.; The relationship between BMI and onset of diabetes mellitus and its complications. South Med J 2015,108(1),29-36","journal-title":"South Med J"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181089","volume":"12","author":"Seliger C.","year":"2017","unstructured":"Seliger C.; Meier C.R.; Becker C.; Diabetes, use of metformin, and the risk of meningioma. PLoS One 2017,12(7)","journal-title":"PLoS One"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.4103\/ijmr.IJMR","volume":"76","author":"Sliwinska A.","year":"2017","unstructured":"Sliwinska A.; Kasznicki J.; Kosmalski M.; Tumour protein 53 is linked with type 2 diabetes mellitus. J Med 2017,76(11),1532-1539","journal-title":"J Med"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-553-8_14","author":"Yin S.","year":"2009","unstructured":"Yin S.; Van Meir E.G.; P53 pathway alterations in brain tumors. In: Meir E, Ed. CNS Cancer. Cancer Drug Discovery and Development. Totowa, New Jersey, USA: Humana Press, 2009"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fendo.2018.00457","volume":"9","author":"Zwezdaryk K.","year":"2018","unstructured":"Zwezdaryk K.; Sullivan D.; Saifudeen Z.; The p53\/adipose-tissue\/cancer nexus. Front Endocrinol (Lausanne) 2018,9,457","journal-title":"Front Endocrinol (Lausanne)"},{"year":"2019","key":"ref=17","unstructured":"Neuro-Oncology Study Group. Book of Teaching Neuro-Oncology. Jakarta: Indonesian Sociey of Neurologist (PERDOSSI) 2019"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-cancerbio-030518-055455","volume":"3","author":"Levine A.","year":"2019","unstructured":"Levine A.; Targeting therapies for the p53 protein in cancer treatments. Annu Rev Cancer Biol 2019,3(1),21-34","journal-title":"Annu Rev Cancer Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/cancers10090297","volume":"10","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Dube C.; Gibert M.; The p53 pathway in glioblastoma. Cancers (Basel) 2018,10(9),297","journal-title":"Cancers (Basel)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/neuonc\/nov100","volume":"18","author":"Seliger C.","year":"2016","unstructured":"Seliger C.; Ricci C.; Meier C.R.; Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro-oncol 2016,18(3),340-349","journal-title":"Neuro-oncol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2337\/dc18-su09","volume":"41","year":"2018","unstructured":"Updates to the Standards of Medical Care in Diabetes-2018. Diabetes Care Association American Diabetes2018,41(9),2045-2047","journal-title":"Diabetes Care"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"16633","DOI":"10.1073\/pnas.0708043104","volume":"104","author":"Feng Z.","year":"2007","unstructured":"Feng Z.; Hu W.; Teresky A.K.; Hernando E.; Cordon-Cardo C.; Levine A.J.; Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci USA 2007,104(42),16633-16638","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.annepidem.2020.06.001","volume":"51","author":"Ogawa T.","year":"2020","unstructured":"Ogawa T.; Sawada N.; Iwasaki M.; Body mass index and height in relation to brain tumor risk in a Japanese population. Ann Epidemiol 2020,51,1-6","journal-title":"Ann Epidemiol"},{"key":"ref=24","unstructured":"American Brain Tumor Association. Astrocytoma. Astrocytoma Learning opportunities Helpful resources 2020. Available from:"},{"journal-title":"Drug Information Handbook: A Comprehensive Resource for all Clinicians and Healthcare Professionals","year":"2012","key":"ref=25","unstructured":"Drug Information Handbook: A Comprehensive Resource for all Clinicians and Healthcare Professionals American Pharmacists Association2012"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/2211-5463.12815","volume":"10","author":"Yang F.","year":"2020","unstructured":"Yang F.; Zou Y.; Gong Q.; Chen J.; Li W.D.; Huang Q.; From astrocytoma to glioblastoma: A clonal evolution study. FEBS Open Bio 2020,10(5),744-751","journal-title":"FEBS Open Bio"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41598-017-01553-2","volume":"7","author":"Schwartzbaum J.","year":"2017","unstructured":"Schwartzbaum J.; Edlinger M.; Zigmont V.; Associations between prediagnostic blood glucose levels, diabetes, and glioma. Sci Rep 2017,7(1),1436","journal-title":"Sci Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ijc.31783","volume":"144","author":"Seliger C.","year":"2019","unstructured":"Seliger C.; Luber C.; Gerken M.; Use of metformin and survival of patients with high-grade glioma. Int J Cancer 2019,144(2),273-280","journal-title":"Int J Cancer"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13256-021-03229-y","volume":"16","author":"Hashimoto H.","year":"2022","unstructured":"Hashimoto H.; Maruo T.; Nakamura M.; Ushio Y.; Hirata M.; Kishima H.; Masked diabetes insipidus in pituitary metastasis from breast cancer after thalamic biopsy: A case report. J Med Case Reports 2022,16(1),12","journal-title":"J Med Case Reports"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3390\/biom11101405","volume":"11","author":"Tseng C.H.","year":"2021","unstructured":"Tseng C.H.; Metformin is associated with a lower incidence of benign brain tumors: A retrospective cohort study in patients with type 2 diabetes mellitus. Biomolecules 2021,11(10),1405","journal-title":"Biomolecules"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/aje\/kwn144","volume":"168","author":"Harder T.","year":"2008","unstructured":"Harder T.; Plagemann A.; Harder A.; Birth weight and subsequent risk of childhood primary brain tumors: A meta-analysis. Am J Epidemiol 2008,168(4),366-373","journal-title":"Am J Epidemiol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/ijms19030776","volume":"19","author":"Itahana Y.","year":"2018","unstructured":"Itahana Y.; Itahana K.; Emerging roles of p53 Family members in glucose metabolism. Int J Mol Sci 2018,19(3),776","journal-title":"Int J Mol Sci"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399818666220519140903","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205028\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399818666220519140903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:09:51Z","timestamp":1683112191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205028\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399818666220519140903","relation":{},"ISSN":["1573-3998"],"issn-type":[{"type":"print","value":"1573-3998"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e190522205028"}}